Ethenyl-[8-[4-(3-methylbutyl)triazol-1-yl]octylimino]-oxidoazanium
C17H31N5O — CID 155519767
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethenyl-[8-[4-(3-methylbutyl)triazol-1-yl]octylimino]-oxidoazanium
Ethenyl-[8-[4-(3-methylbutyl)triazol-1-yl]octylimino]-oxidoazanium (PubChem CID 155519767) has the molecular formula C17H31N5O and a molecular weight of 321.47 g/mol. Its IUPAC name is ethenyl-[8-[4-(3-methylbutyl)triazol-1-yl]octylimino]-oxidoazanium.
Molecular Properties
| Compound Name | Ethenyl-[8-[4-(3-methylbutyl)triazol-1-yl]octylimino]-oxidoazanium |
|---|---|
| PubChem CID | 155519767 |
| Molecular Formula | C17H31N5O |
| Molecular Weight | 321.47 g/mol |
| Exact Mass | 321.25 |
| IUPAC Name | ethenyl-[8-[4-(3-methylbutyl)triazol-1-yl]octylimino]-oxidoazanium |
| SMILES | C=C/[N+]([O-])=N/CCCCCCCCn1cc(CCC(C)C)nn1 |
| InChI | InChI=1S/C17H31N5O/c1-4-22(23)18-13-9-7-5-6-8-10-14-21-15-17(19-20-21)12-11-16(2)3/h4,15-16H,1,5-14H2,2-3H3/b22-18- |
| InChIKey | AYKUSRQLMODCPR-PYCFMQQDSA-N |
| XLogP | 4.31 |
| TPSA | 69.14 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 321.47 |
| LogP ≤ 5 | 4.31 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155519767 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.